• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number WCD 4000
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Inappropriate/Inadequate Shock/Stimulation (1574)
Patient Problems Bradycardia (1751); Ventricular Fibrillation (2130); Shock from Patient Lead(s) (3162); Asystole (4442)
Event Date 04/05/2022
Event Type  Death  
Manufacturer Narrative
The monitor has been returned and the evaluation is underway.The device flag data from the last download does not indicate any device malfunction.The electrode has not been recovered.The device flag data from the last download does not indicate any device malfunction.
 
Event Description
A us distributor contacted zoll to report that a patient passed away while wearing the lifevest on (b)(6) 2022.Review of the download data, indicates the patient received three appropriate treatments during vf and one inappropriate treatment in response to oversensing of cardiac activity.At 00:56:21, the patient received the first appropriate treatment.The patient's rhythm at the time of the treatment event was vf.The patient's post-shock rhythm was sinus bradycardia at 40 bpm.At 00:59:51, the patient received the second appropriate treatment.The patient's rhythm at the time of the treatment event was vf.The patient's post-shock rhythm was sinus bradycardia at 30 bpm with motion artifact.At 01:11:45, the patient received the third appropriate treatment.The patient's rhythm at the time of the treatment event was vf.The patient's post-shock rhythm was asystole with intermittent cardiac activity.At 01:12:16, the patient received the inappropriate treatment during asystole in response to oversensing of cardiac activity.The patient's post-shock rhythm was af at 140 bpm degrading to asystole with intermittent cardiac activity.From 01:12:51 to 12:05:57, the patient was intermittently seen in asystole.Device was shutdown at 12:05:57.Post-shock asystole is a known and potentially adverse outcome of defibrillation therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238 3495
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238 3495
Manufacturer Contact
steven kyle
121 gamma drive
pittsburgh, PA 15238-3495
4129683333
MDR Report Key15199049
MDR Text Key297606628
Report Number3008642652-2022-05656
Device Sequence Number1
Product Code MVK
UDI-Device Identifier00855778005005
UDI-Public00855778005005
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 08/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberWCD 4000
Device Catalogue Number10A0988
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 08/10/2022
Initial Date FDA Received08/10/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/29/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-